Amoxapine: a clinical evaluation in depressive syndromes.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D003863:Depression / Q000188:drug therapy*; D003989:Dibenzoxazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010275:Parasympathetic Nervous System / Q000187:drug effects; D010555:Personality Inventory; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales
D000928:Antidepressive Agents; D003989:Dibenzoxazepines; D010879:Piperazines